The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) halted the use of the Johnson & Johnson COVID-19 vaccine at federally administered sites on April 13, after six cases of blood clots found in women who used the vaccine.
The federal agencies called for a pause at state-administered vaccine sites as well.
